Metformin, an antidiabetic drug, exhibited protective effects against LPS-induced ARDS via the activation of SIRT1, thereby inhibiting NF-κB/NLRP3 pathway–mediated pulmonary vascular ECs pyroptosis. Here, SIRT1 is linked to acute respiratory distress syndrome.